Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Novel delivery strategies for glioblastoma.

Zhou J, Atsina KB, Himes BT, Strohbehn GW, Saltzman WM.

Cancer J. 2012 Jan-Feb;18(1):89-99. doi: 10.1097/PPO.0b013e318244d8ae. Review.

2.

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.

Karim R, Palazzo C, Evrard B, Piel G.

J Control Release. 2016 Apr 10;227:23-37. doi: 10.1016/j.jconrel.2016.02.026. Epub 2016 Feb 16. Review.

PMID:
26892752
3.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
4.

Imaging of convection enhanced delivery of toxins in humans.

Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH.

Toxins (Basel). 2011 Mar;3(3):201-6. doi: 10.3390/toxins3030201. Epub 2011 Mar 15. Review.

5.

Drug delivery approaches for the treatment of glioblastoma multiforme.

Fakhoury M.

Artif Cells Nanomed Biotechnol. 2016 Sep;44(6):1365-73. doi: 10.3109/21691401.2015.1052467. Epub 2015 Jun 5. Review.

PMID:
26046399
6.

Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.

Ningaraj NS, Sankpal UT, Khaitan D, Meister EA, Vats T.

Eur J Pharmacol. 2009 Jan 14;602(2-3):188-93. doi: 10.1016/j.ejphar.2008.10.056. Epub 2008 Nov 9.

PMID:
19027730
7.

Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.

Oberoi RK, Parrish KE, Sio TT, Mittapalli RK, Elmquist WF, Sarkaria JN.

Neuro Oncol. 2016 Jan;18(1):27-36. doi: 10.1093/neuonc/nov164. Epub 2015 Sep 10. Review.

8.

Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

Kim SS, Harford JB, Pirollo KF, Chang EH.

Biochem Biophys Res Commun. 2015 Dec 18;468(3):485-9. doi: 10.1016/j.bbrc.2015.06.137. Epub 2015 Jun 24. Review.

9.

Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.

Juratli TA, Schackert G, Krex D.

Pharmacol Ther. 2013 Sep;139(3):341-58. doi: 10.1016/j.pharmthera.2013.05.003. Epub 2013 May 18. Review.

PMID:
23694764
10.

Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.

Drapeau A, Fortin D.

Curr Cancer Drug Targets. 2015;15(9):752-68. Review.

PMID:
26077730
11.

Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.

Agarwal S, Sane R, Oberoi R, Ohlfest JR, Elmquist WF.

Expert Rev Mol Med. 2011 May 13;13:e17. doi: 10.1017/S1462399411001888. Review.

12.

Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma.

Zhou J, Patel TR, Sirianni RW, Strohbehn G, Zheng MQ, Duong N, Schafbauer T, Huttner AJ, Huang Y, Carson RE, Zhang Y, Sullivan DJ Jr, Piepmeier JM, Saltzman WM.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11751-6. doi: 10.1073/pnas.1304504110. Epub 2013 Jul 1.

13.

A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme.

White E, Bienemann A, Taylor H, Hopkins K, Cameron A, Gill S.

Contemp Clin Trials. 2012 Mar;33(2):320-31. doi: 10.1016/j.cct.2011.10.010. Epub 2011 Nov 12.

PMID:
22101221
14.

Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts.

Yokosawa M, Sonoda Y, Sugiyama S, Saito R, Yamashita Y, Nishihara M, Satoh T, Kumabe T, Yokoyama M, Tominaga T.

Tohoku J Exp Med. 2010 Aug;221(4):257-64.

15.

Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.

Suwala AK, Hanaford A, Kahlert UD, Maciaczyk J.

J Neuropathol Exp Neurol. 2016 May;75(5):388-96. doi: 10.1093/jnen/nlw013. Epub 2016 Mar 15. Review.

PMID:
26979081
16.

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.

Ung TH, Malone H, Canoll P, Bruce JN.

CNS Oncol. 2015;4(4):225-34. doi: 10.2217/cns.15.12. Epub 2015 Jun 24. Review.

PMID:
26103989
17.

Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.

Ferguson S, Lesniak MS.

Curr Drug Deliv. 2007 Apr;4(2):169-80. Review.

PMID:
17456036
18.

Novel drug delivery strategies in neuro-oncology.

Bidros DS, Vogelbaum MA.

Neurotherapeutics. 2009 Jul;6(3):539-46. doi: 10.1016/j.nurt.2009.04.004. Review.

19.

STAT3 as a Therapeutic Target for Glioblastoma.

Liu Y, Li C, Lin J.

Anticancer Agents Med Chem. 2010 Sep;10(7):512-9. Review.

PMID:
20879983
20.

Supplemental Content

Support Center